Colorectal cancer, one of the most common DNA methylated cancers, exhibits decreased expression of the cyclin‐dependent kinase inhibitor 2A (CDKN2A) and Ras association (RalGDS/AF‐6) domain family member 1 (RASSF1A) [49, 50]. Here, CDKN2A is linked to colorectal cancer.